Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience

Yi Li,1,* Yizhao Xie,1,* Chengcheng Gong,1 Yannan Zhao,1 Jian Zhang,1 Sheng Zhang,1 Leiping Wang,1 She Chen,2 Xichun Hu,1 Biyun Wang1 1Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People&...

Full description

Bibliographic Details
Main Authors: Li Y, Xie Y, Gong C, Zhao Y, Zhang J, Zhang S, Wang L, Chen S, Hu X, Wang B
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Therapeutics and Clinical Risk Management
Subjects:
fulvestrant
everolimus
exemestane
metastatic breast cancer
endocrine therapy.
Online Access:https://www.dovepress.com/comparative-treatment-patterns-and-outcomes-of-fulvestrant-versus-ever-peer-reviewed-article-TCRM

Similar Items

Similar Items